Previous Article | Next Article ![]()
Journal of Virology, November 2006, p. 10847-10857, Vol. 80, No. 21
0022-538X/06/$08.00+0 doi:10.1128/JVI.00789-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
,
Department of Botany, University of British Columbia, Vancouver, BC V6T 1Z4, Canada,1 Pacific Agri-Food Research Centre, Box 5000, 4200 Highway 97, Summerland, BC V0H 1Z0, Canada2
Received 18 April 2006/ Accepted 9 August 2006
|
|
|---|
|
|
|---|
Tomato ringspot nepovirus (ToRSV) (a member of the family Comoviridae) has a bipartite genome (35, 36). Each RNA is first translated into a large polyprotein, which is subsequently cleaved into mature and intermediate proteins by a virus-encoded cysteine proteinase (Pro) (11, 20). RNA1 encodes proteins necessary for RNA replication, which include the RNA-dependent RNA polymerase, the proteinase, the genome-linked protein (VPg), and a putative nucleoside triphosphate-binding protein (NTB) (49). In vitro processing studies have also revealed the presence of two additional protein domains (X1 and X2) in the N-terminal region of the RNA1-encoded polyprotein (Fig. 1 A) (51). Similar to other plant picorna-like viruses, ToRSV infection induces severe morphological alterations of ER membranes, and ToRSV VRCs are associated with ER-derived membranes (19, 44). Several viral proteins containing the NTB domain have been detected in infected plants, including the mature NTB protein, the predominant NTB-VPg polyprotein, and a 90-kDa polyprotein which may correspond to the X2-NTB-VPg intermediate polyprotein (19). These proteins are tightly associated with ER membranes and cofractionate with ER-associated VRCs (19). When expressed independently of other viral proteins, the NTB-VPg protein localizes to ER membranes (52). ER binding of the protein is mediated by two regions present in the NTB domain, i.e., a C-terminal transmembrane helix and an N-terminal amphipathic helix (50, 52). These results led us to suggest that NTB and/or a polyprotein containing the NTB domain acts as a membrane anchor for the replication complexes. This suggestion is in agreement with the observation that the 60-kDa protein (equivalent to NTB-VPg) from CPMV, another member of the family Comoviridae, is an ER-targeted protein (7). The ToRSV X2 protein domain shares conserved amino acid motifs with the CPMV 32-kDa protein (35). Both proteins are highly hydrophobic and are situated immediately upstream of the NTB domain in the RNA1-encoded polyprotein. The CPMV 32-kDa protein is an ER-associated protein and has been suggested to play a key role in VRC assembly (7, 31).
![]() View larger version (26K): [in a new window] |
FIG. 1. Computer-assisted
prediction of transmembrane helices (TM) in the ToRSV X2 protein.
(A) Schematic representation of putative transmembrane
helices within the X2 domain. The RNA1-encoded polyprotein is shown at
the top of the panel with the indicated individual protein domains.
Vertical lines represent the cleavage sites recognized by the ToRSV
proteinase. The X2 protein domain is shown below the polyprotein
diagram, with strongly and weakly predicted transmembrane helices
represented by black and gray squares, respectively. The hydrophobicity
plot of X2 is shown at the bottom of the panel. Hydrophobicity was
calculated using the algorithm of Kyte and Doolittle with a window size
of 17 amino acids (26).
(B) Prediction of transmembrane
helices within X2. The entire deduced amino acid sequence of X2
(GenBank accession number DQ469829) is shown at
the top of the panel. Amino acids are numbered from the first amino
acid of the X2 protein domain according to the previously proposed
X1-X2 cleavage site (51).
Predicted transmembrane domains are shown for each program (as
indicated on the left of the panel). Uppercase letters indicate very
high prediction scores, while lowercase letters indicate lower
prediction scores. The amino acid sequences deleted in the TM1, TM2,
TM3, and TM4 deletion mutants are underlined in the X2 sequence. A
naturally occurring putative N-glycosylation site (NMS) is shown by the
arrow.
|
|
|
|---|
TM1, 28/29 for
TM2, and 30/31 for
TM3. To construct the
TM1-2-3 mutant, two rounds of
site-directed mutagenesis were conducted. In the first round, the TM2-3
region was deleted using primer pair 28/31, and in the second round,
the TM1 region was deleted using primer pair 36/37. Agroinfiltration
vectors pBIN-GFP-nN and pBIN-nN-GFP, which contain the SstI/KpnI or
BamHI/KpnI sites, have been described previously
(52). These restriction
sites were used to insert cDNA fragments containing the GFP fusions
mentioned above. Plasmid pBIN19-p19, containing the Tomato bushy
stunt virus suppressor of gene silencing, has also been described
previously (52). To
construct pBIN-X2-HA, the entire coding region of X2 was amplified as
described above using primers 13 (containing an NcoI site) and 79
(containing an Xbal site and the coding sequence for the hemagglutinin
[HA] tag). The PCR fragment was digested with NcoI and XbaI
and ligated into the corresponding sites of plasmid pBBI525. A
KpnI-EcoRI fragment from the resulting plasmid was then transferred
into the binary vector pBIN19.
To construct plasmid pT7-X2,
fragments containing the X2 coding region were amplified as described
above using primers 54 (containing an MscI site) and 53 (containing an
XhoI site). The amplified fragments were digested with MscI and XhoI
and introduced into the corresponding sites of plasmid pCITE-4a
(+) (Novagen). Plasmid pT7-Gln-X2 was constructed in a similar
manner by using primers 52 (containing an MscI site and the coding
region for an introduced N-glycosylation site) and 53. To construct
pT7-X2-Gln, the PCR-based site-directed mutagenesis method was used to
mutate NGH to NGS in the N terminus of GFP in the pX2-GFP plasmid by
using primers 56/57. This resulted in the introduction of an
N-glycosylation site. The resulting plasmid was then used as a template
to amplify a fragment with primer pair 13/55. The amplified fragment
contained the entire X2 coding region and a small portion of the
GFP-coding region, which includes the introduced glycosylation site.
The fragments were digested with NcoI and inserted into the
corresponding site of pCITE-4a (+). Other plasmids were
produced by PCR-based mutagenesis. Plasmids pT7-X2
TM2-Gln,
pT7-X2
TM3-Gln, pT7-X2
TM2-3-Gln,
pT7-X2
TM1-Gln, and pT7-X2
N-Gln were obtained using
pT7-X2-Gln as a template and primer pairs 28/29, 30/31, 28/31, 80/81,
and 84/86, respectively. Similarly, pT7-X2
TM2-3-Gln was used
as a template to produce pT7-X2
TM2-3-4 by using primers 82/83.
Plasmids pT7-Gln-X2
TM1, pT7-Gln-X2
M,
pT7-Gln-X2
N, pT7-Gln-X2
TM3, and
pT7-Gln-X2
TM2-3 were constructed using template pT7-Gln-X2 and
primer pairs 80/81, 85/86, 84/86, 30/31, and 28/31, respectively.
Finally, plasmids pT7-X2
TM3, pT7-X2
TM2-3, and
pT7-X2
TM1 were constructed using plasmid pT7-X2 as a template
and primer pairs 30/31, 28/31 and 80/81,
respectively.
Agroinfiltration of Nicotiana benthamiana plants and confocal microscopy. Binary vectors containing the plant expression cassettes with the X2 fusion proteins were transformed into Agrobacterium tumefaciens LBA4044 (Invitrogen) by electroporation. The transformed bacteria were then used for agroinfiltration as previously described (52). Three days after agroinfiltration, GFP and dsRed2 fluorescence were analyzed with a confocal microscope (Leica) as described previously (52). The acquired images were processed with Leica confocal software and Photoshop 7.0 (Adobe).
Subcellular fractionation and membrane flotation assays. Three to 4 days postagroinfiltration, plant tissues were extracted and fractionated into postnuclear (S3), soluble (S30), and membrane-enriched (P30) fractions as previously described (19, 40). The P30 fraction was resuspended in a volume of homogenization buffer equivalent to that used for the S30 fraction or treated with an equal volume of 1 M NaCl or 0.1 M Na2CO3 (pH 11). Membrane flotation assays were conducted essentially as described previously (52). Briefly, 800 µl of S3 or P30 fraction was adjusted to a final volume of 1.9 ml of 71.5% sucrose (wt/vol) in NTE buffer (100 mM NaCl, 10 mM Tris-HCl [pH 7.5], 1 mM EDTA) and overlaid with 7 ml of 65% sucrose in NTE and 3.1 ml of 10% sucrose in NTE. After centrifugation at 100,000 x g for 18 h, 12 1-ml fractions were collected from the bottom of the tube.
Separation of proteins by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and immunodetection were conducted as previously described (19) using a mouse monoclonal anti-GFP antibody (BD Biosciences), a rat anti-HA antibody (Roche), or a rabbit polyclonal anti-Bip antibody (donated by M. Chrispeels). The secondary antibodies were goat anti-mouse, goat anti-rat, or goat anti-rabbit immunoglobulin G conjugated with horseradish peroxidase (Bio/Can).
In vitro translation assays and deglycosylation assays. Coupled in vitro transcription-translation reactions in the presence or absence of canine microsomal membranes and deglycosylation assays of translation products were conducted as previously described (50).
Computer-assisted multiple-sequence alignments and prediction of putative transmembrane helices and amphipathic helices. Transmembrane helices in nepovirus and comovirus proteins were predicted using the following programs: PHDhtm (34), Sosui (22), Tmpred (23), TMAP (30), TMHMM (43), andHMMTOP (48). Prediction and projection of amphipathic helices were conducted using the Antheprot program (15). Multiple protein sequences were aligned using the ClustalW program (10).
|
|
|---|
![]() View larger version (52K): [in a new window] |
FIG. 2. Multiple-protein-sequence
comparison of the X2 protein domains of nepoviruses and the 32-kDa
protein of comoviruses. (A) Schematic representation of the
RNA1-encoded polyprotein of nepoviruses of subgroups C (ToRSV), B
(Beet ringspot nepovirus [BRSV]), and A (Grapevine fanleaf
nepovirus [GFLV]) and of a comovirus (CPMV). Vertical lines
represent cleavage sites identified by in vitro processing experiments
(21,
27). In the cases of BRSV
and GFLV, two hypothetical cleavage sites are shown by the dashed
lines. The star represents the highly conserved region shown in panel
B. (B) Multiple-protein-sequence alignment of the conserved
region present within the X2 protein domain of five nepoviruses
belonging to subgroup C (ToRSV and Blackcurrant reversion
nepovirus [BRV]), subgroup B (BRSV), and subgroup A (GFLV and
Arabis mosaic nepovirus [ArMV]) and within the CPMV
32-kDa protein. The following GenBank accession numbers
were used to retrieve the sequences from the database:
NC003509 for BRV,
NC003693 for BRSV,
NC003615 for GFLV,
NC006057 for ArMV, and
P03600 for CPMV. The conserved amino acids
present in the "protease cofactor conserved motif"
(F-X28-W-X11-L-X23-E) are
boxed (35). Dots above
the sequence represent amino acids which are similar in all the
sequences. Underlined sequences represent the core regions of
transmembrane helices predicted as shown in Fig.
1B. Only transmembrane
helices predicted by the majority of the programs are shown. Numbering
of amino acids for ToRSV and GFLV is shown according to the proposed
X1-X2 cleavage site (27,
51) and for CPMV
according to the start codon. For other sequences, the X1-X2 cleavage
site has not been identified and amino acids within the sequence were
left
unnumbered.
|
![]() View larger version (51K): [in a new window] |
FIG. 3. Subcellular
fractionation of X2 fusion proteins. (A) Schematic
representation of X2 fusion proteins. The white box represents the X2
domain, while the hatched and black boxes represent the GFP and HA
domains, respectively. The predicted molecular mass of each fusion
protein is indicated in parentheses. (B). Subcellular fractionation of
X2 fusion proteins. Plant tissues expressing the various fusion
proteins were fractionated into soluble (S) and
membrane-enriched (P) fractions as described in Materials and
Methods. Proteins were separated by SDS-PAGE (12% for lanes 1 to 8 and
15% for lanes 9 to 12) and detected by immunoblotting with anti-GFP
(lanes 1 to 8) or anti-HA (lanes 9 to 12) monoclonal antibodies.
Migration of molecular mass standards is indicated on the left (lanes 1
to 8) or right (lanes 9 to 12) side. ck, negative control transfected
with pBin-p19 only. (C) Membrane flotation assays. Equal
volumes of postnuclear (S3) fractions derived from plants expressing
GFP-X2, X2-GFP, X2-HA, or unfused GFP were used for membrane flotation
assays as described in Materials and Methods. Fractions were collected
from the step sucrose gradient, and proteins present in each collected
fraction (as indicated at the top of the panel) were separated by
SDS-PAGE and immunodetected using anti-GFP, anti-HA, or anti-Bip
antibody. Only the relevant parts of the gels are shown. In the case of
X2-GFP, P30 fractions of X2-GFP were incubated for 30 min at
4°C in extraction buffer (Extr. Buffer) or in solutions of 1 M
NaCl or 0.1 M Na2CO3 (pH 11) before the flotation
assay.
|
![]() View larger version (45K): [in a new window] |
FIG. 4. Subcellular
localization of GFP-X2 and X2-GFP. GFP fusions and ER-dsRed2 (an ER
marker) were expressed in leaves of N. benthamiana by using
agroinfiltration as described in Materials and Methods. Epidermal cells
were examined 3 days after agroinfiltration by confocal microscopy. In
the merge panel, the colocalization of the GFP fluorescence (green) and
of the ER marker fluorescence (red) results in a yellow color. Panels
2, 4, and 6 are close-up views of regions included in the white squares
in panels 1, 3, and 5. Bars on the merged images represent 10
µm.
|
The presence of the GFP fusion proteins in P30 fractions may result from true membrane association or simply protein aggregation. To distinguish between these two possibilities, we used a membrane flotation assay. In this assay, total plant extracts (S3) are overlaid with a sucrose gradient and subjected to centrifugation. Low-density membranes and proteins associated with these membranes float to the upper part of the gradient while soluble proteins or aggregated proteins remain at the bottom. We used Bip (an endogenous ER luminal protein) (45) and unfused GFP as controls. As shown in Fig. 3C, Bip rose towards the top of the gradient (fractions 8 and 9) while GFP remained at the bottom of the gradient (fractions 1 and 2). GFP-X2 and X2-GFP were found in fractions 8 and 9, confirming that they are membrane associated.
To investigate the nature of the association of X2-GFP with membranes, we treated the P30 fractions containing X2-GFP with Na2CO3 (0.1 M, pH 11) and NaCl (1 M) and then conducted membrane flotation assays. These chemicals are known to release peripheral membrane proteins from the membranes but not integral membrane proteins (24, 39). X2-GFP was found in the membrane fraction (fraction 9) after both treatments, suggesting that it interacts directly with the lipid bilayer of the membrane (Fig. 3C).
To provide further evidence that X2 is a membrane-associated protein, we also fused the entire protein to a smaller epitope tag (X2-HA, in which the HA epitope tag is fused to the C terminus of X2) (Fig. 3A). X2-HA was mainly detected in the P30 fraction (Fig. 3B, lanes 11 and 12) and floated to the top of the gradient in a membrane flotation assay (Fig. 3C).
X2 contains multiple ER-targeting domains.
The tight association of X2-GFP fusion
proteins with ER membranes prompted us to investigate sequence elements
within X2 mediating the membrane association. We first generated
several mutants of X2-GFP in which the hydrophobic segments TM1, TM2,
and TM3 were deleted either individually or in combination (Fig.
5A, constructs
TM1,
TM2,
TM3, and
TM1-2-3). We found that all four X2 derivatives retained the
ability to associate with the ER, i.e., they had patterns of
fluorescence similar to those in the wild-type X2-GFP in confocal
images (compare Fig. 4 and
Fig.
6). They were also partitioned to membrane-enriched
fractions in subcellular fractionation experiments (Fig.
5B). We then fused
different portions of X2 (Fig.
5A, constructs TM1, TM2-3,
TM2, TM3, cX2, and mX2) to the N terminus of GFP and tested whether any
given fragment could target GFP to the ER. The fluorescence associated
with the TM1 and cX2 fusion proteins did not overlap with that of
ER-dsRed2 (Fig. 6). The
proteins were detected in both the S30 and the P30 fractions (Fig.
5C). However, the presence
of these proteins in the P30 fraction was probably due to protein
aggregation rather than to membrane association, as the proteins
remained at the bottom of the gradient in the membrane flotation assays
(Fig. 5D). The highly
hydrophobic TM2 and TM3 domains targeted the GFP to the ER membrane
when fused to GFP individually (TM2 and TM3) or in combination (TM2-3)
(Fig. 6). Targeting to the
ER was partial when only one of the hydrophobic regions was included
(as evidenced by the presence of some fluorescence within the nucleus
with TM2 and TM3) (Fig. 6
and data not shown). The TM2 and TM3 proteins were partitioned in both
the S30 and P30 fractions (Fig.
5C). The full-length,
33-kDa TM2-3 fusion protein was found predominantly in the P30
fraction. A 30-kDa truncated protein which may correspond to
degradation products of the full-length protein was also detected in
the S30 fraction. The TM2, TM3, and full-length TM2-3 fusion proteins
present in the P30 fraction floated to the top of the gradient in
membrane flotation assays, confirming that they are membrane associated
(Fig. 5D). Surprisingly,
although no hydrophobic sequence was predicted in this region, mX2 was
found to associate with the ER in confocal pictures, fractionated with
the membrane-enriched P30 fraction and partitioned with the membranes
in the flotation assays (Fig.
6 and
5C and D). We treated the
P30 fractions of mX2 with Na2CO3 (0.1 M, pH 11)
and NaCl (1 M), which were separated subsequently into S30 and P30
fractions. We found that mX2 was present in the P30 fraction after the
treatment, suggesting a direct interaction between mX2 and the lipid
bilayer of the membranes (Fig.
5E). Taken together, these
results suggested that X2 contains three ER-targeting domains,
including two highly hydrophobic C-terminal regions and an additional
domain further upstream.
![]() View larger version (61K): [in a new window] |
FIG. 5. Subcellular
fractionation of X2-GFP mutant derivatives. (A) Schematic
representation of X2-GFP derivatives. Only the X2 domains are shown in
the panel. The GFP domain (not shown) is fused to the C terminus of
each X2 derivative. The predicted transmembrane domains are shown with
gray and black boxes as in Fig.
1. The predicted molecular
mass (M) of each GFP fusion protein and the amino acids (a.a.) of X2
included in each fusion protein are shown on the right. (B and C)
Subcellular fractionation of X2-GFP derivatives. Soluble (S)
and membrane-enriched (P) fractions were prepared from plants
expressing mutated X2-GFP proteins as described in Materials and
Methods. Proteins were separated by SDS-PAGE (12%) and immunodetected
with anti-GFP antibody. Migration of molecular mass standards is shown
on the right of each gel. (D) Membrane flotation assays. For
TM1, mX2, and cX2, postnuclear (S3) fractions were used for the
flotation assays. In the cases of TM2, TM3, and TM2-3, P30 fractions
were used. Fractions were collected from the step sucrose gradient, and
proteins present in each collected fraction were separated by SDS-PAGE
(12%) and immunodetected with the anti-GFP antibody. (E)
Biochemical treatments of membrane-enriched fractions derived from
plants expressing mX2. Membrane-enriched (P30) fractions from Fig.
4C were treated with 0.1 M
Na2CO3 (pH 11) or 1 M NaCl for 30 min at
4°C. After separation of membrane-bound (P) and
soluble (S) proteins, the presence of mX2 in these fractions
was revealed by immunoblotting with the anti-GFP
antibody.
|
![]() View larger version (26K): [in a new window] |
FIG. 6. Subcellular
localization of X2-GFP derivatives in epidermal cells of N.
benthamiana. Plants expressing X2-GFP derivatives and an ER marker
(ER-dsRed2) were examined using confocal microscopy 3 days after
agroinfiltration. Pictures represent portions of a single cell,
including the nucleus (shown by the arrow) and the cortical ER
network.
|
![]() View larger version (38K): [in a new window] |
FIG. 7. In
vitro glycosylation assays of wild-type or mutated X2. On the left is a
schematic representation of the various X2 constructs. The predicted
transmembrane domains are shown with gray and black boxes as in Fig.
1. Amino acids (a.a.)
inserted at the N or C termini of the proteins are shown with dark
lines. Introduced N-glycosylation signals are represented by black
Y's. A naturally occurring putative N-glycosylation site is shown
by the white Y, although this site was not recognized in any of the
mutants tested. The dashed lines represent deleted regions within X2.
The name of each construct is indicated on the left, and the amino
acids of the X2 domain contained in each construct are indicated in the
middle. In vitro glycosylation assays are shown on the right. Each
protein was translated in the presence (+) or absence
() of canine microsomal membranes (MM). The translation
products were further treated with endoglycosydase F (PNGase F),
separated by SDS-PAGE, and detected by autoradiography. Only the
relevant portions of the gels are shown. N.T., not
tested.
|
TM3-Gln mutant) would result in the
translocation of the C terminus of the protein in the lumen of the
membrane. As expected, glycosylation of this mutant readily occurred in
the presence of the membrane. This glycosylation was not due to the
recognition of the internal NMS sequence, as the control X2
TM3
mutant remained unglycosylated. Introduction of this mutation in the
Gln-X2 protein did not alter its state of glycosylation, suggesting
that deletion of TM3 did not affect the orientation of the N-terminal
region of the protein (compare mutant Gln-X2
TM3 to Gln-X2).
Similarly, deletion of TM2 from the X2-Gln protein resulted in the
reorientation of the C terminus of the protein in the lumen
(X2
TM2-Gln mutant). These results provide support for the
suggestion that TM2 and TM3 form a hairpin in the membrane. To confirm
this, we deleted both domains from the X2-Gln protein
(X2
TM2-3-Gln). Unexpectedly, glycosylation was still observed,
although it was much reduced compared to that of the X2
TM3-Gln
mutant. As described above, this glycosylation was not due to the
recognition of the internal NMS sequence, as the X2
TM2-3
mutant was not glycosylated. To determine whether the putative TM4
domain played a role in the translocation of the C terminus of the
protein in the membrane lumen, we constructed a triple mutant in which
TM2, TM3, and TM4 were deleted. Low levels of glycosylation were still
observed in this new mutant, suggesting that TM4 was not a primary
determinant of the membrane topology. We conclude that an additional
domain upstream of TM2 is likely responsible for the low level of
glycosylation observed in the X2
TM2-3-Gln and
X2
TM2-3-4-Gln proteins.
To investigate which region of
X2 is responsible for the translocation of the N terminus of the
protein in the lumen, we introduced a series of mutations in the Gln-X2
protein. First, we deleted both TM2 and TM3 (Gln-X2
TM2-3).
Glycosylation of this mutant was still observed, suggesting that a
region of X2 present between the N terminus of the protein and the TM2
domain acts as a transmembrane domain (Fig.
7). We then deleted the
entire N-terminal region of X2 (Gln-X2
N). Translocation of the
N terminus of the protein was eliminated, confirming the presence of a
transmembrane segment in this region. This result is consistent with
the in planta observation that an ER-targeting domain is present in the
mX2-GFP fusion protein. TM1 is the only hydrophobic region predicted by
computer. However, deletion of TM1 in the context of Gln-X2
(Gln-X2
TM1) did not prevent the glycosylation. The observed
glycosylation was due to the recognition of the introduced N-terminal
glycosylation site, as the control X2
TM1 mutant remained
unglycosylated. A stretch of 35 amino acids located immediately
upstream of the TM2 domain was also deleted (mutant Gln-X2
M).
Glycosylation of this mutant was still observed. Based on these
results, we tentatively suggest that a region confined within amino
acids 38 to 62 may be involved in the membrane association and in the
translocation of the N terminus of X2 in the membrane lumen. Finally,
the
N and
TM1 deletions were also introduced in the
X2-Gln protein. The X2
N-Gln and X2
TM1-Gln mutants
remained unglycosylated, suggesting that deletion of the N-terminal
region of the protein did not affect the orientation of its C
terminus.
|
|
|---|
Although the ToRSV X2 protein and the CPMV 32-kDa protein both target GFP to ER membranes, the fluorescence patterns of these proteins are somewhat different. Fluorescence associated with the ToRSV X2-GFP fusion protein is evenly distributed in the cortical ER network and in the perinuclear ER. No obvious membrane proliferation or alteration of membrane morphology was observed. In contrast, the CPMV 32-kDa protein-GFP fusion is specifically targeted to the cortical ER (7). It also induces aggregation of cortical ER and formation of small bodies near the nucleus. One possibility is that the different behaviors of the two fusion proteins are due to intrinsic properties of the two proteins, possibly modulated by divergent sequences outside the conserved motif. Alternatively, the differences observed could be due to the experimental system used. In this study, the fusion proteins were expressed by agroinfiltration, while in the CPMV study, the fusion proteins were expressed from a viral vector.
In this study, we have identified three distinct membrane-association domains within X2, i.e., two C-terminal transmembrane helices (TM2 and TM3) and a third, less-well-defined domain within the mX2 region. Each of the three elements could direct GFP to the ER membranes independently (Fig. 6). This observation is further supported by our in vitro glycosylation study, which suggests that all three domains have the ability to traverse the membranes (Fig. 7). Based on these results, we propose a model for the topology of X2 in the membrane (Fig. 8A). In this model, the N terminus of X2 is oriented in the lumen while the C terminus is cytosolic. The protein traverses the membrane three times.
![]() View larger version (20K): [in a new window] |
FIG. 8. Topological
model of X2 in ER membranes. (A) Proposed topological model
of X2. On the top of the panel is the linear representation of membrane
association domains of X2. The light gray regions represent hydrophobic
domains (TM1 and TM4, as in Fig.
1) that do not traverse
the membranes. Transmembrane -helices TM2 and TM3 are shown by
the black boxes as in Fig.
1. The star represents a
putative amphipathic helix. Below the domain diagram is the topological
model of X2 in ER membranes. The double-lipid layer of the membranes is
represented by the two shaded horizontal lines. The predicted
orientations of the various transmembrane domains within the membrane
are shown. (B) Helical wheel projection of a putative
amphipathic helix located between amino acids 46 and
63.
|
N protein,
which includes the TM2 and TM3 domains but not the upstream membrane
association domain, is oriented towards the cytosolic face of the
membrane.
The observation that the central region of X2 (mX2)
contains an ER-targeting sequence and probably traverses the membrane
at least in vitro is surprising, as this region is largely hydrophilic
and is not predicted to contain transmembrane domains (Fig.
1). A putative amphipathic
helix is present between amino acids 46 and 63 and may be responsible
for the translocation of the N terminus of the protein in the lumen
(Fig. 8B). Similar
putative amphipathic helices were also found at equivalent positions in
the X2 protein domains of other nepoviruses and in the CPMV 32-kDa
protein (data not shown). Amphipathic helices are initially oriented
parallel to the membrane, with their hydrophobic faces towards the
membrane and their hydrophilic faces towards the cytosol. Translocation
of amphipathic helices across membranes usually involves the
oligomerization of the amphipathic helix at the membrane surface
followed by insertion of the oligomers into the membrane in a
posttranslational manner through the barrel stave mechanism
(2,
42). The X2 putative
amphipathic helix may be inserted in the membrane in either
orientation, providing a possible explanation for our observation that
both Gln-X2
TM2-3 and X2
TM2-3-Gln are glycosylated. In
fact, dual orientation of transmembrane segments has been documented
(29). In the context of
the wild-type X2 protein, the presence of the TM2 and TM3 domains may
force the putative amphipathic helix to adopt a type I topology
(in-out) (Fig. 8A). A
similar situation was reported for the human band 3 protein, in which a
downstream transmembrane domain dictated the orientation of upstream
transmembrane segments
(28). Further
experimentation will be required to confirm the role of the proposed
amphipathic helix in membrane association.
In this study, the topology of the mature X2 protein was analyzed. However, the protein is initially produced as a polyprotein in which X2 is located immediately upstream of the NTB domain. Also, intermediate polyproteins containing both the X2 and the NTB domains are likely to be present in infected cells. In fact, in addition to the NTB and NTB-VPg proteins, a 90-kDa membrane-associated protein containing the NTB domain, which may correspond to the X2-NTB-VPg polyprotein, was previously detected in infected plants (19). Previous analysis of the topology of NTB-VPg in ER membranes by in vitro glycosylation assays revealed that the N terminus of NTB is translocated into the ER lumen (52). This would be in apparent contradiction with the results presented here indicating that the C terminus of the mature X2 protein is oriented towards the cytosolic face of the membrane. One possible explanation is that in the context of the polyproteins, the C terminus of X2 or the N terminus of NTB adopts an orientation different from that observed with the mature proteins. Dual topology has been observed for the p7 protein of hepatitis C virus, in which case the protein adopts a different orientation when it is present within a larger polyprotein that also includes the E2 domain (E2-p7) (25). We have previously shown that the translocation of the N terminus of NTB-VPg in the lumen is directed by a putative amphipathic helix, which probably requires oligomerization to traverse the membrane (52). Although it is tempting to suggest that this process is inhibited in the context of larger polyproteins that contain the X2 domain, further experimentation will be required to resolve this issue.
The polytopic nature of X2 is reminiscent of that of the 2B protein of poliovirus. Both proteins are located immediately upstream of the NTB domain (2C in the case of poliovirus). The 2B protein of poliovirus has been shown to increase membrane permeability by forming a pore in the membrane (1). Recent evidence suggests that pore formation regulates the calcium concentrations of endoplasmic reticulum membranes and may play a role in preventing defensive apoptotic host cell response (5). It will be interesting to investigate whether X2 has the ability to modify membrane permeability or not.
This work was supported in part by an NSERC discovery grant awarded to H.S.
Published ahead of print on 23 August 2006. ![]()
Supplemental material for this article may be found at
http://jvi.asm.org/. ![]()
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»